Company Overview of Theron Pharmaceuticals Inc.
Theron Pharmaceuticals Inc., a biotechnology company, develops long acting M3 muscarinic antagonist (LAMA) products for the treatment of chronic respiratory diseases. Its lead development candidate includes TRN-157, a preclinical development therapy that focuses on treating chronic obstructive pulmonary disease and severe asthma. The company was founded in 2008 and is based in Sunnyvale, California.
365 San Aleso Avenue
Sunnyvale, CA 94085
Founded in 2008
Key Executives for Theron Pharmaceuticals Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Theron Pharmaceuticals Inc., please visit www.theronpharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.